Transforming Health Together
ISGlobal Annual Report 2025
SCROLL TO DISCOVER
A shared reflection
in a changing world

2025 has been a year of intense geopolitical tension, eroding the multilateralism and cooperation that global health depends on. Ongoing conflicts, a fragmenting global trade system, a global decline in development aid, and the rise of AI-driven disinformation have strained trust and international collaboration. At the same time, environmental and climate-related threats have intensified, with a surge in mosquito-borne diseases such as chikungunya and West Nile virus, and extreme climate events -heatwaves, floods and wildfires- affecting millions. But despite these challenges, there have been positive developments: the Seville Commitment reaffirmed support for development cooperation, the WHO Pandemic Agreement marked a step forward in global preparedness, and COP30 advanced the Belém Health Action Plan to strengthen health systems’ adaptation to climate change.
Generating evidence for action
Within this landscape, ISGlobal’s research has continued to generate evidence to inform policy and practice. Our researchers estimated the lives saved through international development aid, and warned of the consequences of its defunding. A series of studies deepened
our understanding of how air pollution during pregnan

“A key priority this year has been to strengthen how our research translates into societal impact.”
Quique Bassat i Denise Naniche
General Director and Scientific Director.
Defining moments of 2025
Connecting science across borders
Projects and networks
coordinated by ISGlobal
Main international institutions with which ISGlobal published scientific articles during 2025
A word of thanks
Agència de Gestió d’Ajuts
Universitaris i Recerca (AGAUR)
Agència Catalana de Cooperació al Desenvolupament (ACCD)
Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (ANSES)
Agencia Española de Cooperación Internacional para el Desarrollo (AECID)
Ajuntament de Barcelona
Australian Catholic University (ACU)
Bill & Melinda Gates Foundation (BMGF)
Centro de Investigación Biomédica en Red (CIBER)
Diputació de Barcelona
European & Developing Countries Clinical Trial Partnership (EDCTP)
European Commission (FP7, H2020)
European Respiratory Society (ERS)
Formas (Forskningsrådet F Miljö, Areella Näringar Och Samhällsbyggande)
Fondation Daniel et Nina Carasso
Fundacion Biodiversidad
Fundación Bancaria “la Caixa”
Fundación Ramón Areces
Fundació La Marató de TV3
Fundació Privada Daniel
Bravo Andreu
Generalitat de Catalunya
Global Health Innovative Technology Fund (GHIT Fund)
Gilead Sciences
Glaxosmithkline Investigación Y Desarrollo (GSK)
Hospital Clínic i Provincial de Barcelona
Instituto de Salud Carlos III (ISCI III)
Ministerio de Ciencia e Innovación
Ministerio de Educación y Formación Profesional
National Institutes of Health (NIH)
Novartis















